Literature DB >> 9554520

The clinicopathologic significance of small areas unstained by Lugol's iodine in the mucosa surrounding resected esophageal carcinoma: an analysis of 147 cases.

Y Nakanishi1, A Ochiai, K Yoshimura, H Kato, T Shimoda, H Yamaguchi, Y Tachimori, H Watanabe, S Hirohashi.   

Abstract

BACKGROUND: Small areas unstained with Lugol's iodine are often observed in the mucosa surrounding esophageal carcinomas.
METHODS: For light microscopic evaluation, the histologic features of 131 small areas unstained by Lugol's iodine in 12 selected cases were investigated. For clinicopathologic evaluation, the numbers of small areas unstained by Lugol's iodine in the mucosa surrounding 147 consecutively resected esophageal carcinomas, including these 12 cases, were counted. The relation between the incidence of such areas and the development of multiple primary cancers in the upper aerodigestive tract was examined together with data on the patients' tobacco and alcohol consumption.
RESULTS: Ninety-two percent (131) of the small areas unstained by Lugol's iodine contained dysplastic lesions. Seventeen (12%) of the 147 resected specimens contained fewer than 5 small unstained areas, whereas 52 (35%) had 6-10 and 78 (53%) had more than 11 such areas. The incidence of multicentric cancer in the upper aerodigestive tract and the average alcohol index scores were significantly higher for patients who had more than 11 unstained areas than for patients who had fewer than 5 such areas (P < 0.01).
CONCLUSIONS: Lugol's iodine staining method is useful for detecting groups at high risk of multicentric cancer in the upper aerodigestive tract.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9554520

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Oral premalignant lesions: from a clinical perspective.

Authors:  Teruo Amagasa; Masashi Yamashiro; Narikazu Uzawa
Journal:  Int J Clin Oncol       Date:  2011-01-12       Impact factor: 3.402

2.  Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients.

Authors:  M Muto; Y Hitomi; A Ohtsu; S Ebihara; S Yoshida; H Esumi
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

3.  Molecular analysis in combination with iodine staining may contribute to the risk prediction of esophageal squamous cell carcinoma.

Authors:  Shun He; Guang-Ming Guo; Fu-Xing Liu; Xiao-Ping Huang; Xin Xu; Yan Cai; Ya-Ling Han; Qi-Min Zhan; Min Wu; Jin-Tang Dong; Gui-Qi Wang; Ming-Rong Wang
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-14       Impact factor: 4.553

4.  Telomerase activity of the Lugol-stained and -unstained squamous epithelia in the process of oesophageal carcinogenesis.

Authors:  M Inai; M Kano; Y Shimada; T Sakurai; T Chiba; M Imamura
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

5.  Evaluation of Oral Mucosal Lesions Using the IllumiScan® Fluorescence Visualisation Device: Distinguishing Squamous Cell Carcinoma.

Authors:  Yuki Taguchi; Shigeaki Toratani; Kensaku Matsui; Seiya Hayashi; Natsuki Eboshida; Atsuko Hamada; Nanako Ito; Fumitaka Obayashi; Naohiro Kimura; Souichi Yanamoto
Journal:  Int J Environ Res Public Health       Date:  2022-08-21       Impact factor: 4.614

6.  LIHNCS - Lugol's iodine in head and neck cancer surgery: a multicentre, randomised controlled trial assessing the effectiveness of Lugol's iodine to assist excision of moderate dysplasia, severe dysplasia and carcinoma in situ at mucosal resection margins of oral and oropharyngeal squamous cell carcinoma: study protocol for a randomised controlled trial.

Authors:  James A McCaul; James A Cymerman; Stuart Hislop; Chris McConkey; Jeremy McMahon; Hisham Mehanna; Richard Shaw; David N Sutton; Janet Dunn
Journal:  Trials       Date:  2013-09-24       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.